ORLANDO — In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, discusses the real-world use of aflibercept 8 mg in wet age-related macular degeneration or diabetic macular edema.
A study of data from the IRIS Registry looked at how clinicians use Eylea HD (aflibercept 8 mg, Regeneron) in patients with treatment-naive wet AMD or DME and patients who had received prior treatment with Eylea (aflibercept 2 mg, Regeneron) before switching to Eylea HD.
In treatment-naive patients, the injection interval could be extended to 12 weeks in DME and wet AMD after